BankInvest Biomedical Venture
9
19M
7
0.38
3
0.22
2
- Stages of investment
- Areas of investment
Summary
In 1998 was created BankInvest Biomedical Venture, which is appeared as VC.
Besides, a startup needs to be aged 4-5 years to get the investment from the fund. The fund has no exact preference in a number of founders of portfolio startups. If startup sums 3 or 5+ of the founder, the chance for it to be financed is low. Among the most popular portfolio startups of the fund, we may highlight Genmab, F2G, Nereus Pharmaceuticals. Among the most popular fund investment industries, there are Medical, Health Care.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the BankInvest Biomedical Venture, startups are often financed by Pacific Venture Group, Novartis Venture Fund, Gimv. The meaningful sponsors for the fund in investment in the same round are ODYSSEE VENTURE, Idinvest Partners, Dansk Erhvervsinvestering. In the next rounds fund is usually obtained by Sunstone Life Science Ventures, Novartis Venture Fund, Merifin Capital.
The fund is constantly included in less than 2 deals per year. The usual things for fund are deals in the range of 10 - 50 millions dollars. The increased amount of exits for fund were in 2019. This BankInvest Biomedical Venture works on 4 percentage points less the average amount of lead investments comparing to the other organizations. The important activity for fund was in 2005. The real fund results show that this VC is 18 percentage points more often commits exit comparing to other companies.
Investments analytics
Analytics
- Total investments
- 9
- Lead investments
- 3
- Exits
- 2
- Rounds per year
- 0.38
- Follow on index
- 0.22
- Investments by industry
- Biotechnology (9)
- Health Care (8)
- Medical (6)
- Biopharma (3)
- Pharmaceutical (3) Show 4 more
- Investments by region
-
- Denmark (3)
- United Kingdom (2)
- United States (1)
- France (2)
- Sweden (1)
- Peak activity year
- 2005
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 23
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Resistentia Pharmaceuticals | 26 Sep 2006 | Biotechnology, Health Care, Medical Device, Therapeutics | Late Stage Venture | 14M | Uppsala County, Uppsala, Sweden |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.